Literature DB >> 8589719

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor.

R Rozmahel1, M Wilschanski, A Matin, S Plyte, M Oliver, W Auerbach, A Moore, J Forstner, P Durie, J Nadeau, C Bear, L C Tsui.   

Abstract

Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction. We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium-activated Cl- conductance. Identification of modifier genes in our Cftr(m1HSC)/Cftr(m1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8589719     DOI: 10.1038/ng0396-280

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  102 in total

1.  Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype.

Authors:  Richard Rozmahel; Howard T J Mount; Fusheng Chen; Van Nguyen; Jean Huang; Serap Erdebil; Jennifer Liauw; Gang Yu; Hiroshe Hasegawa; YongJun Gu; You-Qiang Song; Stephen D Schmidt; Ralph A Nixon; Paul M Mathews; Catherine Bergeron; Paul Fraser; David Westaway; Peter St George-Hyslop
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-18       Impact factor: 11.205

2.  Severe defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels.

Authors:  Marcelo A Catalán; Carlos A Flores; Mireya González-Begne; Yan Zhang; Francisco V Sepúlveda; James E Melvin
Journal:  Gastroenterology       Date:  2011-11-10       Impact factor: 22.682

Review 3.  Purinergic regulation of epithelial transport.

Authors:  R Elaine Bucheimer; Joel Linden
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

Review 4.  Atypical cystic fibrosis--diagnostic and management dilemmas.

Authors:  Colin Wallis
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 5.  Use of knock-out mouse models for the study of renal ion channels.

Authors:  H Barrière; M Tauc; P Poujeol
Journal:  J Membr Biol       Date:  2004-04-01       Impact factor: 1.843

6.  A mouse model for X-linked adrenoleukodystrophy.

Authors:  J F Lu; A M Lawler; P A Watkins; J M Powers; A B Moser; H W Moser; K D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Complementation of null CF mice with a human CFTR YAC transgene.

Authors:  A L Manson; A E Trezise; L J MacVinish; K D Kasschau; N Birchall; V Episkopou; G Vassaux; M J Evans; W H Colledge; A W Cuthbert; C Huxley
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 8.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 9.  Cystic fibrosis modifier genes.

Authors:  Jane Davies; Eric Alton; Uta Griesenbach
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

Review 10.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.